| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
|
J Invest Dermatol
|
2006
|
1.59
|
|
2
|
Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
|
Acta Derm Venereol
|
2010
|
1.51
|
|
3
|
Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.
|
J Invest Dermatol
|
2003
|
1.30
|
|
4
|
1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression.
|
Arch Dermatol Res
|
2004
|
1.14
|
|
5
|
Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin.
|
J Invest Dermatol
|
2003
|
1.09
|
|
6
|
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
|
J Immunol
|
2006
|
1.08
|
|
7
|
The activity of caspase-1 is increased in lesional psoriatic epidermis.
|
J Invest Dermatol
|
2007
|
1.07
|
|
8
|
IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms.
|
J Invest Dermatol
|
2007
|
1.04
|
|
9
|
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.
|
J Invest Dermatol
|
2007
|
0.96
|
|
10
|
Caspase-5 expression is upregulated in lesional psoriatic skin.
|
J Invest Dermatol
|
2010
|
0.95
|
|
11
|
MK2 regulates the early stages of skin tumor promotion.
|
Carcinogenesis
|
2009
|
0.95
|
|
12
|
Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB.
|
J Biol Chem
|
2011
|
0.94
|
|
13
|
Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
|
Exp Dermatol
|
2013
|
0.91
|
|
14
|
Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
|
J Invest Dermatol
|
2005
|
0.90
|
|
15
|
1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
|
J Invest Dermatol
|
2003
|
0.89
|
|
16
|
Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients.
|
Acta Derm Venereol
|
2012
|
0.88
|
|
17
|
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis.
|
Exp Dermatol
|
2011
|
0.88
|
|
18
|
HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris.
|
Arch Dermatol
|
2003
|
0.87
|
|
19
|
National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines.
|
Arch Dermatol Res
|
2013
|
0.87
|
|
20
|
Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.
|
Exp Dermatol
|
2007
|
0.87
|
|
21
|
Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries.
|
Acta Derm Venereol
|
2013
|
0.87
|
|
22
|
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.
|
J Invest Dermatol
|
2008
|
0.85
|
|
23
|
Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.
|
Cancer Invest
|
2011
|
0.85
|
|
24
|
Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis.
|
J Invest Dermatol
|
2007
|
0.84
|
|
25
|
The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.
|
PLoS One
|
2010
|
0.84
|
|
26
|
Immunosuppressive therapy in dermatology and PML.
|
J Dtsch Dermatol Ges
|
2009
|
0.83
|
|
27
|
Signal transduction pathways in human epidermis.
|
Eur J Dermatol
|
2005
|
0.83
|
|
28
|
Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity.
|
Eur J Dermatol
|
2006
|
0.83
|
|
29
|
The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice.
|
Exp Dermatol
|
2010
|
0.83
|
|
30
|
Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate.
|
Acta Derm Venereol
|
2011
|
0.82
|
|
31
|
New vitamin D analogs in psoriasis.
|
Curr Drug Targets Inflamm Allergy
|
2004
|
0.82
|
|
32
|
Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity.
|
Acta Derm Venereol
|
2004
|
0.81
|
|
33
|
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
|
Dan Med J
|
2012
|
0.80
|
|
34
|
Juvenile psoriasis and its clinical management: a European expert group consensus.
|
J Dtsch Dermatol Ges
|
2010
|
0.80
|
|
35
|
Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report.
|
Acta Derm Venereol
|
2013
|
0.78
|
|
36
|
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin.
|
Exp Dermatol
|
2014
|
0.78
|
|
37
|
IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.
|
Acta Derm Venereol
|
2013
|
0.77
|
|
38
|
Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006).
|
Am J Clin Dermatol
|
2012
|
0.77
|
|
39
|
CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.
|
Cytokine
|
2011
|
0.77
|
|
40
|
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
|
Int J Dermatol
|
2006
|
0.77
|
|
41
|
Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis.
|
Int J Dermatol
|
2014
|
0.75
|
|
42
|
Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1alpha,25-dihydroxyvitamin D3-induced differentiation.
|
Arch Dermatol Res
|
2003
|
0.75
|
|
43
|
KID Syndrome: report of a Scandinavian patient with connexin-26 gene mutation.
|
Acta Derm Venereol
|
2005
|
0.75
|
|
44
|
[Biological dermatologic agents. The Danish Society of Dermatology].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
45
|
[Hereditary angioedema].
|
Ugeskr Laeger
|
2004
|
0.75
|
|
46
|
[Quality and documentation prior to dermatological laser treatment].
|
Ugeskr Laeger
|
2005
|
0.75
|